Animal experiments suggest that opiate peptides might play a role in extrapyramidal function. This hypothesis was tested by administering the opiate antagonist, naltrexone, in doses sufficient to antagonize exogenous opiates, to patients with parkinsonism and Huntington's disease. No improvement in the clinical features of either disorder was noted.
|Original language||English (US)|
|Number of pages||2|
|Journal||Archives of Neurology|
|State||Published - Dec 1978|
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Clinical Neurology